-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics CEO Martine Rothblatt disposes of 8,500 common shares worth $4.63 million

PUBT·07/02/2026 20:34:23
Listen to the news
United Therapeutics CEO Martine Rothblatt disposes of 8,500 common shares worth $4.63 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares on July 1, 2026 at USD 135.42.
  • Rothblatt sold 9,500 shares the same day at weighted-average prices ranging from about USD 537.58 to USD 549.14.
  • Directly held common shares fell to 40,513 following the transactions.
  • Directly held stock options increased to 77,718.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000090), on July 02, 2026, and is solely responsible for the information contained therein.